Earnings Updates, FLASH Headline Alerts

Earnings Update: JNJ Beats on Top and Bottom Lines, Guides Lower

Johnson-Johnson Logo

Sign Up to Receive an Email Alert when Flash Headlines are Published

Earnings Update: Johnson & Johnson (NYSE: JNJ)

Johnson & Johnson reported Q1 earnings per share of $1.56, which was above the FactSet estimate for $1.53.

Revenues for the quarter were reported at $17.37 billion, which was above the estimate of $17.31 billion.

The company guided Full Year EPS to a range of $6.04-6.19 vs prior guidance $6.12-6.27 and FactSet $6.19 .

“The company delivered strong underlying growth in the first quarter driven by new products and the strength of the core business. Of note is the continued robust growth of the Pharmaceutical business and the solid performance of our Consumer brands,” said Alex Gorsky, Chairman and Chief Executive Officer. “I am proud of our global teams who focus every day on delivering innovative solutions to address evolving health care needs.

Shares of JNJ last traded at $100.85, which is up slightly from the last closing price of $100.55.

 


Are You Using the Right Strategy at the Right Time?

Check out the SmartMix ® Strategy
Keeping Clients Focused on the Right Strategy at the Right Time

Performance Update: +10.0% in 2014
+393% from 2008 strategy inception
Fact Sheets Available on Website



Remember, you are in control your email alerts! You can receive alerts for more than 20 free research report alerts including: The “10.0” Report, The Insiders Report, ETF Leaders Report, and The Focus List.

 

About the Author

David Moenning is the Chief Investment Officer at Sowell Management Services. Dave began his investment career in 1980 and has been an independent money manager since 1987. Thus, Dave has been live on the firing line and investing for a living for more than 29 years.